There are likely additional mechanisms that can lead to decreased levels of CGN and PTPRR because not all cancers show increased expression of miR-100[38] or miR-125b[39], but the data are in agreement that decreased levels of CGN and PTPRR correlate with cancer. The gene discussed is CGN; the disease is cancer.